Skip to main content
. 2018 Jun 12;8:8935. doi: 10.1038/s41598-018-27319-y

Figure 2.

Figure 2

Recurrence-free survival of hepatocellular carcinoma patients after liver transplantation according to quartiles of peak 7-day postoperative bilirubin concentration (A), international normalized ratio (B), and gamma-glutamyl transpeptidase activity (C).